Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Eagle Pharmaceuticals, Inc. (EGRX)

« Back to company index

EGRX Chatter Timeline

Stock Ticker for EGRX

Most Active Tweeters for EGRX

UserTweets
@AmericanBanking 4
@whatsonthorold2 4
@ThisLincolnian 3
@TickerReport 3
@ConsumerFeed 3

Recent Tweets for EGRX

whatsonthorold2 @whatsonthorold2
Is Buying Stock Like Eagle Pharmaceuticals, Inc. $EGRX After Such Increase Winning Strategy? https://t.co/1RJDsgdLIh
March 21st 2019, 5:03pm
bulletin_en @bulletin_en
Eagle Pharmaceuticals Inc $EGRX Sellers Declined Their Shorts By 2.42% As Of Mar 21, 2019 https://t.co/8g0sagGdzs
March 21st 2019, 5:03pm
myQuikfo @myQuikfo
Today's Health Care market mover is EAGLE PHARMACEUTICALS INC $EGRX is up 6.10%! Key words: EXPECTING, REPORT, POSI… https://t.co/Wr53kJ3yFb
March 21st 2019, 12:03pm
ZolmaxNews @ZolmaxNews
Brokerages Set Eagle Pharmaceuticals Inc $EGRX Price Target at $69.80 https://t.co/BDex5P9DoB
March 20th 2019, 1:03pm
dailypoliticaln @dailypoliticaln
Brokerages Set Eagle Pharmaceuticals Inc $EGRX Price Target at $69.80 https://t.co/RM0tPfw5sa
March 20th 2019, 1:03pm
ConsumerFeed @ConsumerFeed
Eagle Pharmaceuticals $EGRX Upgraded to “Hold” by ValuEngine https://t.co/bN8qy75GrS
March 20th 2019, 5:03am
reurope_stock @reurope_stock
Eagle Pharmaceuticals $EGRX Valuation Declined While Jw Asset Management Has Lowered Its Stake; As Wells Fargo Co N… https://t.co/VaYUbS0vmR
March 19th 2019, 11:03am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $EGRX is $1.01 it's 2.05% of the current price https://t.co/fQqaTFkfbT
March 19th 2019, 3:03am
TickerReport @TickerReport
Eagle Pharmaceuticals $EGRX Upgraded to Hold by ValuEngine https://t.co/J70r81FRSS
March 19th 2019, 1:03am
dailypoliticaln @dailypoliticaln
Eagle Pharmaceuticals $EGRX Upgraded to Hold by ValuEngine https://t.co/AH6BUTf3zu
March 19th 2019, 1:03am
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals Inc $EGRX Expected to Announce Quarterly Sales of $53.97 Million https://t.co/yA3epkf5bs
March 17th 2019, 11:03pm
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals Inc $EGRX Given Consensus Rating of “Hold” by Brokerages https://t.co/KPvih0LLD7 #stocks
March 17th 2019, 8:03am
TranscriptDaily @TranscriptDaily
Eagle Pharmaceuticals Inc $EGRX Expected to Announce Quarterly Sales of $53.97 Million https://t.co/X1qVtwUsks
March 15th 2019, 7:03pm
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals Inc $EGRX Expected to Announce Earnings of $1.02 Per Share https://t.co/KBer8gAnIg
March 15th 2019, 7:03pm
WeekHerald @WeekHerald
Eagle Pharmaceuticals $EGRX – Investment Analysts’ Weekly Ratings Updates https://t.co/V8accn9KNx
March 15th 2019, 9:03am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals $EGRX – Investment Analysts’ Weekly Ratings Updates https://t.co/t0CJSN54vX #stocks
March 15th 2019, 9:03am
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals $EGRX – Investment Analysts’ Weekly Ratings Updates https://t.co/Gy7j42upUh
March 15th 2019, 9:03am
whatsonthorold2 @whatsonthorold2
Are Analysts Bearish Eagle Pharmaceuticals, Inc. $EGRX After Last Week? https://t.co/THgaFaqxLj
March 14th 2019, 3:03pm
WatchlistN @WatchlistN
$53.97 Million in Sales Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/jYycNMV9Yc
March 13th 2019, 8:03pm
TickerReport @TickerReport
Eagle Pharmaceuticals Inc $EGRX Expected to Post Quarterly Sales of $53.97 Million https://t.co/MULGyiUkJQ
March 13th 2019, 8:03pm
whatsonthorold2 @whatsonthorold2
Eagle Pharmaceuticals Inc $EGRX Shorted Shares Decreased By 2.42% https://t.co/cIPCe2l2Zp
March 13th 2019, 4:03pm
bibeypost_stock @bibeypost_stock
Eagle Pharmaceuticals Inc $EGRX’s Trend Up, Especially After Decreased Shorts https://t.co/fUAM0k3Zmw
March 13th 2019, 4:03pm
stocknewstimes @stocknewstimes
Analysts Expect Eagle Pharmaceuticals Inc $EGRX to Announce $1.02 Earnings Per Share https://t.co/OyopNA4NxQ
March 11th 2019, 10:03am
TheMarketsDaily @TheMarketsDaily
$1.02 Earnings Per Share Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/U6A9rFsQle
March 11th 2019, 9:03am
ConsumerFeed @ConsumerFeed
Capital Impact Advisors LLC Increases Stake in Eagle Pharmaceuticals Inc $EGRX https://t.co/KcwXyyieEW
March 11th 2019, 8:03am
whatsonthorold2 @whatsonthorold2
How Analysts Rated Eagle Pharmaceuticals, Inc. $EGRX Last Week? https://t.co/cimeVwfiC3
March 10th 2019, 4:03pm
bulletin_en @bulletin_en
Summary of Eagle Pharmaceuticals, Inc. $EGRX Ratings https://t.co/zRYOX72c81
March 10th 2019, 8:03am
dispatchtribune @dispatchtribune
$55.80 Million in Sales Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/7LpGzRM42F
March 10th 2019, 7:03am
registrarjourn @registrarjourn
Zacks: Brokerages Expect Eagle Pharmaceuticals Inc $EGRX Will Post Quarterly Sales of $55.80 Million https://t.co/HG6yU4gLCE
March 10th 2019, 7:03am
EnterpriseLeade @EnterpriseLeade
Zacks: Brokerages Expect Eagle Pharmaceuticals Inc $EGRX Will Post Quarterly Sales of $55.80 Million https://t.co/c75RO43819
March 10th 2019, 7:03am
AmericanBanking @AmericanBanking
Zacks: Brokerages Expect Eagle Pharmaceuticals Inc $EGRX Will Post Quarterly Sales of $55.80 Million https://t.co/X1DVOk8rAT #stocks
March 10th 2019, 7:03am
ChartMill @ChartMill
$EGRX has only a medium technical rating, but it does show a decent setup pattern. https://t.co/1DxrlZIEf3 https://t.co/ZUQA2feciH
March 9th 2019, 2:03pm
ConsumerFeed @ConsumerFeed
Eagle Pharmaceuticals $EGRX Upgraded to “Buy” by BidaskClub https://t.co/XnjtJWsodB
March 9th 2019, 3:03am
TickerReport @TickerReport
Eagle Pharmaceuticals $EGRX Upgraded to “Buy” by BidaskClub https://t.co/j9wszMXiLg
March 8th 2019, 3:03pm
WatchlistN @WatchlistN
Eagle Pharmaceuticals $EGRX Lifted to “Buy” at BidaskClub https://t.co/EQbVJMr5g9
March 8th 2019, 3:03pm
bbnsnews @bbnsnews
$0.75 EPS Expected for Eagle Pharmaceuticals Inc $EGRX This Quarter https://t.co/y1uPly1zNi
March 8th 2019, 1:03am
AmericanBanking @AmericanBanking
Brokerages Expect Eagle Pharmaceuticals Inc $EGRX to Announce $0.75 EPS https://t.co/LpHN1vm7sd #stocks
March 8th 2019, 1:03am
dailypoliticaln @dailypoliticaln
Eagle Pharmaceuticals $EGRX Raised to Buy at BidaskClub https://t.co/LgKMfYfOO6
March 7th 2019, 1:03pm
reurope_stock @reurope_stock
Were Analysts Bearish Eagle Pharmaceuticals, Inc. $EGRX This Week? https://t.co/not4GA2pAX
March 7th 2019, 12:03pm
dispatchtribune @dispatchtribune
Insider Selling: Eagle Pharmaceuticals Inc $EGRX CEO Sells 24,428 Shares of Stock https://t.co/YwBUjjhFft
March 7th 2019, 5:03am
registrarjourn @registrarjourn
Insider Selling: Eagle Pharmaceuticals Inc $EGRX CEO Sells $1,249,980.76 in Stock https://t.co/eQft8Xy1yV
March 7th 2019, 5:03am
EnterpriseLeade @EnterpriseLeade
Insider Selling: Eagle Pharmaceuticals Inc $EGRX CEO Sells $1,249,980.76 in Stock https://t.co/JrciGqfaZQ
March 7th 2019, 5:03am
InsiderAlertsIA @InsiderAlertsIA
$EGRX: New Insider Filing on Director STEVEN B RATOFF: https://t.co/pekPeaCH63
March 6th 2019, 4:03pm
whatsonthorold2 @whatsonthorold2
Will Eagle Pharmaceuticals Inc $EGRX Run Out of Steam Soon? Short Interest Is Down https://t.co/2nL9vmYgUq
March 6th 2019, 1:03pm
reurope_stock @reurope_stock
Will Eagle Pharmaceuticals Inc $EGRX Run Out of Steam Soon? Short Interest Is Down https://t.co/bA8Z77UnFW
March 6th 2019, 1:03pm
FinZTribune @FinZTribune
2.42% Less Eagle Pharmaceuticals Inc $EGRX Shares Shorted https://t.co/xoy8RP218M
March 6th 2019, 11:03am
TranscriptDaily @TranscriptDaily
Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Buy” https://t.co/EYO11dOzHB
March 6th 2019, 9:03am
stocknewstimes @stocknewstimes
Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Buy” https://t.co/VaUqEIk8Cg
March 6th 2019, 9:03am
FinZTribune @FinZTribune
Summary of Eagle Pharmaceuticals, Inc. $EGRX Ratings on Mar 6, 2019 https://t.co/geZy9csUvA
March 6th 2019, 8:03am
TickerReport @TickerReport
Scott Tarriff Sells 24,428 Shares of Eagle Pharmaceuticals Inc $EGRX Stock https://t.co/FLbfb63bmd
March 6th 2019, 4:03am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.